-
1
-
-
0027430748
-
Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor
-
Klingmuller U, Schaller H. Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor. J Virol 1993;67:7414-22.
-
(1993)
J Virol
, vol.67
, pp. 7414-7422
-
-
Klingmuller, U.1
Schaller, H.2
-
2
-
-
0029070471
-
Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles
-
Pugh JC, Di Q, Mason WS, et al. Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles. J Virol 1995;69:4814-22.
-
(1995)
J Virol
, vol.69
, pp. 4814-4822
-
-
Pugh, J.C.1
Di Mason Q, W.S.2
-
3
-
-
0029975078
-
Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus
-
Yan RQ, Su JJ, Huang DR, et al. Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus. J Cancer Res Clin Oncol 1996;122:283-8.
-
(1996)
J Cancer Res Clin Oncol
, vol.122
, pp. 283-288
-
-
Yan, R.Q.1
Su, J.J.2
Huang, D.R.3
-
4
-
-
0343026658
-
Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus
-
Kock J, et al. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol 2001;75:5084-9.
-
(2001)
J Virol
, vol.75
, pp. 5084-5089
-
-
Kock, J.1
-
5
-
-
35148812988
-
Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes
-
Chai N, Chang HE, Nicolas E, et al. Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes. J Virol 2007;81:10897-904.
-
(2007)
J Virol
, vol.81
, pp. 10897-10904
-
-
Chai, N.1
Chang, H.E.2
Nicolas, E.3
-
7
-
-
0028295258
-
A cell surface protein that binds avian hepatitis B virus particles
-
Kuroki K, Cheung R, Marion PL, et al. A cell surface protein that binds avian hepatitis B virus particles. J Virol 1994;68:2091-6.
-
(1994)
J Virol
, vol.68
, pp. 2091-2096
-
-
Kuroki, K.1
Cheung, R.2
Marion, P.L.3
-
8
-
-
0034766658
-
A short sequence within domain C of duck carboxypeptidase D is critical for duck hepatitis B virus binding and determines host specificity
-
Spangenberg HC, Lee HB, Li J, et al. A short sequence within domain C of duck carboxypeptidase D is critical for duck hepatitis B virus binding and determines host specificity. J Virol 2001;75:10630-42.
-
(2001)
J Virol
, vol.75
, pp. 10630-10642
-
-
Spangenberg, H.C.1
Lee, H.B.2
Li, J.3
-
9
-
-
0028856080
-
Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection
-
Tong S, Li J, Wands Jr. Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection. J Virol 1995;69:7106-12.
-
(1995)
J Virol
, vol.69
, pp. 7106-7112
-
-
Tong, S.1
Li, J.2
Wands, J.R.3
-
10
-
-
0032823294
-
Carboxypeptidase D is an avian hepatitis B virus receptor
-
Tong S, Li J, Wands Jr. Carboxypeptidase D is an avian hepatitis B virus receptor. J Virol 1999;73:8696-702.
-
(1999)
J Virol
, vol.73
, pp. 8696-8702
-
-
Tong, S.1
Li, J.2
Wands, J.R.3
-
11
-
-
84879327902
-
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
-
Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 2012;1: e00049.
-
(2012)
ELife
, vol.1
-
-
Yan, H.1
Zhong, G.2
Xu, G.3
-
12
-
-
0024347431
-
Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective
-
Neurath AR, Seto B, Strick N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine 1989;7:234-6.
-
(1989)
Vaccine
, vol.7
, pp. 234-236
-
-
Neurath, A.R.1
Seto, B.2
Strick, N.3
-
13
-
-
34249816178
-
Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues
-
Blanchet M, Sureau C. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J Virol 2007;81:5841-9.
-
(2007)
J Virol
, vol.81
, pp. 5841-5849
-
-
Blanchet, M.1
Sureau, C.2
-
14
-
-
0032981014
-
Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain
-
Le Seyec J, Chouteau P, Cannie I, et al. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J Virol 1999;73:2052-7.
-
(1999)
J Virol
, vol.73
, pp. 2052-2057
-
-
Le Seyec, J.1
Chouteau, P.2
Cannie, I.3
-
15
-
-
22544433180
-
Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition
-
Barrera A, Guerra B, Notvall L, et al. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J Virol 2005;79:9786-98.
-
(2005)
J Virol
, vol.79
, pp. 9786-9798
-
-
Barrera, A.1
Guerra, B.2
Notvall, L.3
-
16
-
-
22344442543
-
Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes
-
Glebe D, Urban S, Knoop EV, et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 2005;129:234-45.
-
(2005)
Gastroenterology
, vol.129
, pp. 234-245
-
-
Glebe, D.1
Urban, S.2
Knoop, E.V.3
-
17
-
-
13744257618
-
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein
-
Gripon P, Cannie I, Urban S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol 2005;79:1613-22.
-
(2005)
J Virol
, vol.79
, pp. 1613-1622
-
-
Gripon, P.1
Cannie, I.2
Urban, S.3
-
18
-
-
0028345733
-
Duck hepatitis B virus infection of Muscovy duck hepatocytes and nature of virus resistance in vivo
-
Pugh JC, Simmons H. Duck hepatitis B virus infection of Muscovy duck hepatocytes and nature of virus resistance in vivo. J Virol 1994;68:2487-94.
-
(1994)
J Virol
, vol.68
, pp. 2487-2494
-
-
Pugh, J.C.1
Simmons, H.2
-
19
-
-
34548572892
-
Bile acid transporters: Structure, function, regulation and pathophysiological implications
-
Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res 2007;24:1803-23.
-
(2007)
Pharm Res
, vol.24
, pp. 1803-1823
-
-
Alrefai, W.A.1
Gill, R.K.2
-
21
-
-
0019501267
-
Light microscopic localization of hepatitis B virus antigens in the human pancreas. Possibility of multiplication of hepatitis B virus in the human pancreas
-
Shimoda T, Shikata T, Karasawa T, et al. Light microscopic localization of hepatitis B virus antigens in the human pancreas. Possibility of multiplication of hepatitis B virus in the human pancreas. Gastroenterology 1981;81:998-1005.
-
(1981)
Gastroenterology
, vol.81
, pp. 998-1005
-
-
Shimoda, T.1
Shikata, T.2
Karasawa, T.3
-
22
-
-
80054991427
-
Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT
-
Hu NJ, Iwata S, Cameron AD, et al. Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT. Nature 2011;478:408-11.
-
(2011)
Nature
, vol.478
, pp. 408-411
-
-
Hu, N.J.1
Iwata, S.2
Cameron, A.D.3
-
23
-
-
0034667323
-
Structural and functional characterization of liver cell-specific activity of the human sodium/taurocholate cotransporter
-
Shiao T, Iwahashi M, Fortune J, et al. Structural and functional characterization of liver cell-specific activity of the human sodium/taurocholate cotransporter. Genomics 2000;69:203-13.
-
(2000)
Genomics
, vol.69
, pp. 203-213
-
-
Shiao, T.1
Iwahashi, M.2
Fortune, J.3
-
24
-
-
1942423712
-
Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene
-
Jung D, Hagenbuch B, Fried M, et al. Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. Am J Physiol Gastrointest Liver Physiol 2004;286:G752-761.
-
(2004)
Am J Physiol Gastrointest Liver Physiol
, vol.286
-
-
Jung, D.1
Hagenbuch, B.2
Fried, M.3
-
25
-
-
1342304081
-
Ethnicity-dependent polymorphism in Na +-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition
-
Ho RH, Leake BF, Roberts RL, et al. Ethnicity-dependent polymorphism in Na +-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition. J Biol Chem 2004;279:7213-22.
-
(2004)
J Biol Chem
, vol.279
, pp. 7213-7222
-
-
Ho, R.H.1
Leake, B.F.2
Roberts, R.L.3
-
26
-
-
0035123573
-
Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice
-
Raney AK, Eggers CM, Kline EF, et al. Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J Virol 2001;75:2900-11.
-
(2001)
J Virol
, vol.75
, pp. 2900-2911
-
-
Raney, A.K.1
Eggers, C.M.2
Kline, E.F.3
-
27
-
-
0029130068
-
High-level hepatitis B virus replication in transgenic mice
-
Guidotti LG, Matzke B, Schaller H, et al. High-level hepatitis B virus replication in transgenic mice. J Virol 1995;69:6158-69.
-
(1995)
J Virol
, vol.69
, pp. 6158-6169
-
-
Guidotti, L.G.1
Matzke, B.2
Schaller, H.3
-
28
-
-
84874588814
-
Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP)
-
Dong Z, Ekins S, Polli JE. Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP). Mol Pharm 2013;10:1008-19.
-
(2013)
Mol Pharm
, vol.10
, pp. 1008-1019
-
-
Dong, Z.1
Ekins, S.2
Polli, J.E.3
|